proxyvotesnow.com

Home › Companies › ASTRIA THERAPEUTICS INC. › 2024-2025

ASTRIA THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and ASTRIA THERAPEUTICS INC.’s Form 8-K, filed 2025-06-12 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 7Reported items
  • 133Asset managers
  • 1,014Fund votes
  • 2025-06-11Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ASTRIA THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by ASTRIA THERAPEUTICS INC.

These tallies are ASTRIA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ASTRIA THERAPEUTICS INC. — official shareholder meeting results, meeting held 2025-06-11
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Jill C. Milne 49,955,122---- 200,1603,401,529 Majority: yes
Elect Director: Fred Callori 43,513,443---- 6,641,8393,401,529 Majority: yes
Elect Director: Michael Kishbauch 42,381,788---- 7,773,4943,401,529 Majority: yes
Proposal 2 . The stockholders of the Company approved the first amendment to the Second Amended and Restated 2015 Plan to increase the number of shares of common stock available for grant under the plan by five million, five hundred thousan 42,460,4197,684,29310,570 --3,401,529 Passed
Proposal 3 . The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. 53,498,11753,2935,401 ---- Passed
Proposal 4 . The stockholders of the Company approved, on an advisory basis, the compensation of the Company's named executive officers. 43,538,6926,611,4515,139 --3,401,529 Passed

Source: ASTRIA THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-12 — read the filing on EDGAR.

How asset managers voted at the ASTRIA THERAPEUTICS INC. 2024-2025 meeting

Each item below shows how the 133 asset managers that disclosed a ASTRIA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ASTRIA THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. THE APPROVAL, BY NON-BINDING ADVISORY VOTE, OF OUR EXECUTIVE COMPENSATION.

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Combines 4 wordings of this item as funds reported it.

87% Passed · of votes cast

FOR 87%13%
FOR: 43,538,692AGAINST: 6,611,451

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Proposal 4 . The stockholders of the Company approved, on an advisory basis, the compensation of the Company's named executive officers.”): 43,538,692 for, 6,611,451 against — passed, per its Form 8-K filed 2025-06-12 (Item 5.07).

The 128 asset managers below cast 89% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 89%11%
FOR: 89.1%AGAINST: 10.9%NOT VOTED: 0.0%
Largest asset managers voting on “THE APPROVAL, BY NON-BINDING ADVISORY VOTE, OF OUR EXECUTIVE COMPENSATION.” at ASTRIA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity12,989,163500 00For
PERCEPTIVE ADVISORS LLC6,319,4800 00For
FCPM III SERVICES B.V.4,107,5370 00For
RA CAPITAL MANAGEMENT, L.P.4,041,0910 00For
Fairmount Funds Management LLC3,554,1290 00For
BlackRock3,381,5175,033 00For
Vestal Point Capital, LP03,115,185 00Against
TCG Crossover Management, LLC2,761,8610 00For
Vanguard2,674,7072,714 00For
VR Adviser, LLC2,457,3480 00For
Vivo Capital, LLC1,552,6850 00For
GEODE CAPITAL MANAGEMENT, LLC986,4650 00For
Citadel914,8720 00For
DRIEHAUS CAPITAL MANAGEMENT LLC0863,004 00Against
State Street835,11113,534 00For
ADAR1 Capital Management, LLC0711,688 00Against
Nantahala Capital Management, LLC643,3180 00For
Charles Schwab633,8720 00For
Logos Global Management LP500,0000 00For
Northern Trust374,3287,805 00For
DAFNA Capital Management LLC324,7750 00For
DRIEHAUS MUTUAL FUNDS0234,776 00Against
MELLON INVESTMENTS Corp151,3620 00For
Equitable81,16554,020 00For
Point720122,011 00Against

Showing the 25 largest of 128 asset managers. See all 128 in the interactive database.

2. The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Fred Callori

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%13%
FOR: 43,513,443WITHHELD: 6,641,839

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Fred Callori”): 43,513,443 for, 6,641,839 withheld, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 42 asset managers below cast 100% of the shares they voted on this item FOR (11,304,983 for, 0 against).

FOR 94%
FOR: 11,304,983 (94.3%)ABSTAIN: 686,975 (5.7%)
Largest asset managers voting on “The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 20” at ASTRIA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity6,127,9920 5000For
Vanguard2,579,3920 00For
BlackRock1,927,8390 00For
Charles Schwab316,9360 00For
DRIEHAUS MUTUAL FUNDS00 234,7760Abstain
Equitable81,1650 54,0200For
RBB FUND, INC.00 104,0110Abstain
TIAA99,9820 00For
Brinker Capital Destinations Trust1,0910 53,8390Abstain
American Century00 53,4860Abstain
ALPS ETF Trust00 43,4440Abstain
Northern Trust39,3630 00For
Lincoln Financial33,4000 00For
Global X27,3960 00For
AIG/SunAmerica00 23,6400Abstain
John Hancock00 17,4890Abstain
Pacific Life15,1950 00For
Brighthouse00 14,8760Abstain
Nationwide14,4190 00For
FORUM FUNDS II00 14,3090Abstain
Voya00 13,4330Abstain
ETFis Series Trust I00 12,5270Abstain
MASTER INVESTMENT PORTFOLIO11,2480 00For
ProShares00 11,2050Abstain
Thrivent00 9,9730Abstain

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

3. The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Jill C. Milne

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 49,955,122WITHHELD: 200,160

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jill C. Milne”): 49,955,122 for, 200,160 withheld, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 42 asset managers below cast 100% of the shares they voted on this item FOR (11,985,844 for, 0 against).

FOR 99.9%
FOR: 11,985,844 (99.9%)ABSTAIN: 6,114 (0.1%)
Largest asset managers voting on “The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 20” at ASTRIA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity6,128,4920 00For
Vanguard2,579,3920 00For
BlackRock1,927,8390 00For
Charles Schwab316,9360 00For
DRIEHAUS MUTUAL FUNDS234,7760 00For
Equitable135,1850 00For
RBB FUND, INC.104,0110 00For
TIAA99,9820 00For
Brinker Capital Destinations Trust54,9300 00For
American Century53,4860 00For
ALPS ETF Trust43,4440 00For
Northern Trust39,3630 00For
Lincoln Financial33,4000 00For
Global X27,3960 00For
AIG/SunAmerica23,6400 00For
John Hancock17,4890 00For
Pacific Life15,1950 00For
Brighthouse14,8760 00For
Nationwide14,4190 00For
FORUM FUNDS II14,3090 00For
Voya13,4330 00For
ETFis Series Trust I12,5270 00For
MASTER INVESTMENT PORTFOLIO11,2480 00For
ProShares11,2050 00For
Thrivent9,9730 00For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

4. The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Michael Kishbauch

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%
FOR: 42,381,788WITHHELD: 7,773,494

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael Kishbauch”): 42,381,788 for, 7,773,494 withheld, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 42 asset managers below cast 100% of the shares they voted on this item FOR (11,228,059 for, 0 against).

FOR 94%
FOR: 11,228,059 (93.6%)ABSTAIN: 763,899 (6.4%)
Largest asset managers voting on “The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 20” at ASTRIA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity6,127,9920 5000For
Vanguard2,579,3920 00For
BlackRock1,927,8390 00For
Charles Schwab316,9360 00For
DRIEHAUS MUTUAL FUNDS00 234,7760Abstain
Equitable81,1650 54,0200For
RBB FUND, INC.00 104,0110Abstain
TIAA99,9820 00For
Brinker Capital Destinations Trust1,0910 53,8390Abstain
American Century00 53,4860Abstain
ALPS ETF Trust00 43,4440Abstain
Northern Trust00 39,3630Abstain
Lincoln Financial33,4000 00For
Global X00 27,3960Abstain
AIG/SunAmerica00 23,6400Abstain
John Hancock00 17,4890Abstain
Pacific Life15,1950 00For
Brighthouse00 14,8760Abstain
Nationwide14,4190 00For
FORUM FUNDS II00 14,3090Abstain
Voya00 13,4330Abstain
ETFis Series Trust I00 12,5270Abstain
MASTER INVESTMENT PORTFOLIO11,2480 00For
ProShares00 11,2050Abstain
Thrivent00 9,9730Abstain

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

5. THE APPROVAL OF THE FIRST AMENDMENT TO OUR SECOND AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN, TO INCREASE THE NUMBER OF SHARES OF OUR COMMON STOCK AVAILABLE FOR GRANT UNDER THE PLAN BY 5,500,000 SHARES.

COMPENSATIONCompany result: Passed

Combines 2 wordings of this item as funds reported it.

85% Passed · of votes cast

FOR 85%AGAINST 15%
FOR: 42,460,419AGAINST: 7,684,293

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Proposal 2 . The stockholders of the Company approved the first amendment to the Second Amended and Restated 2015 Plan to increase the number of shares of common stock available for grant under the plan by five million, ”): 42,460,419 for, 7,684,293 against — passed, per its Form 8-K filed 2025-06-12 (Item 5.07).

The 42 asset managers below cast 93% of the shares they voted on this item FOR (11,154,070 for, 837,888 against).

FOR 93%
FOR: 11,154,070 (93.0%)AGAINST: 837,888 (7.0%)
Largest asset managers voting on “THE APPROVAL OF THE FIRST AMENDMENT TO OUR SECOND AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN, TO INCREASE ” at ASTRIA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity6,127,992500 00For
Vanguard2,579,3920 00For
BlackRock1,927,8390 00For
Charles Schwab316,9360 00For
DRIEHAUS MUTUAL FUNDS0234,776 00Against
Equitable81,16554,020 00For
RBB FUND, INC.0104,011 00Against
TIAA099,982 00Against
Brinker Capital Destinations Trust054,930 00Against
American Century053,486 00Against
ALPS ETF Trust043,444 00Against
Northern Trust39,3630 00For
Lincoln Financial033,400 00Against
Global X27,3960 00For
AIG/SunAmerica023,640 00Against
John Hancock017,489 00Against
Pacific Life15,1950 00For
Brighthouse014,876 00Against
Nationwide14,4190 00For
FORUM FUNDS II014,309 00Against
Voya013,433 00Against
ETFis Series Trust I012,527 00Against
MASTER INVESTMENT PORTFOLIO11,2480 00For
ProShares011,205 00Against
Thrivent09,973 00Against

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

6. THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATEDCompany result: Passed

Combines 2 wordings of this item as funds reported it.

99.9% Passed · of votes cast

FOR 99.9%
FOR: 53,498,117AGAINST: 53,293

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Proposal 3 . The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”): 53,498,117 for, 53,293 against — passed, per its Form 8-K filed 2025-06-12 (Item 5.07).

The 42 asset managers below cast 100% of the shares they voted on this item FOR (11,991,958 for, 0 against).

FOR 100%
FOR: 11,991,958 (100.0%)
Largest asset managers voting on “THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ” at ASTRIA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity6,128,4920 00For
Vanguard2,579,3920 00For
BlackRock1,927,8390 00For
Charles Schwab316,9360 00For
DRIEHAUS MUTUAL FUNDS234,7760 00For
Equitable135,1850 00For
RBB FUND, INC.104,0110 00For
TIAA99,9820 00For
Brinker Capital Destinations Trust54,9300 00For
American Century53,4860 00For
ALPS ETF Trust43,4440 00For
Northern Trust39,3630 00For
Lincoln Financial33,4000 00For
Global X27,3960 00For
AIG/SunAmerica23,6400 00For
John Hancock17,4890 00For
Pacific Life15,1950 00For
Brighthouse14,8760 00For
Nationwide14,4190 00For
FORUM FUNDS II14,3090 00For
Voya13,4330 00For
ETFis Series Trust I12,5270 00For
MASTER INVESTMENT PORTFOLIO11,2480 00For
ProShares11,2050 00For
Thrivent9,9730 00For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

7. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Combines 2 wordings of this item as funds reported it.

87% Passed · of votes cast

FOR 87%13%
FOR: 43,538,692AGAINST: 6,611,451

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Proposal 4 . The stockholders of the Company approved, on an advisory basis, the compensation of the Company's named executive officers.”): 43,538,692 for, 6,611,451 against — passed, per its Form 8-K filed 2025-06-12 (Item 5.07).

The 4 asset managers below cast 0.1% of the shares they voted on this item FOR (478 for, 623,452 against).

AGAINST 99.9%
FOR: 478 (0.1%)AGAINST: 623,452 (99.9%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at ASTRIA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
ADAGE CAPITAL PARTNERS GP, L.L.C.0588,200 00Against
JPMorgan020,943 00Against
FORUM FUNDS II014,309 00Against
GAMMA Investing LLC4780 00For

Largest ASTRIA THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked by the number of ASTRIA THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting.

Top ASTRIA THERAPEUTICS INC. shareholders by shares voted, 2024-2025
#Asset manager Shares voted
1Fidelity 12,989,663
2PERCEPTIVE ADVISORS LLC 6,319,480
3FCPM III SERVICES B.V. 4,107,537
4RA CAPITAL MANAGEMENT, L.P. 4,041,091
5Fairmount Funds Management LLC 3,554,129
6BlackRock 3,386,550
7Vestal Point Capital, LP 3,115,185
8TCG Crossover Management, LLC 2,761,861
9Vanguard 2,677,421
10VR Adviser, LLC 2,457,348

Shown as share counts, not percentages: no shares-outstanding figure has been matched to ASTRIA THERAPEUTICS INC. for the 2024-2025 season, so there is no denominator to divide by.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At ASTRIA THERAPEUTICS INC.'s shareholder meeting held 2025-06-11, in the 2024-2025 proxy season, 133 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,014 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — THE APPROVAL, BY NON-BINDING ADVISORY VOTE, OF OUR EXECUTIVE COMPENSATION. — the proposal passed with 87% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ASTRIA THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-12.

ASTRIA THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.